• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Evidence-Based and Patient-Oriented Inositol Treatment in Polycystic Ovary Syndrome: Changing the Perspective of the Disease.

作者信息

Laganà Antonio Simone, Rossetti Paola, Sapia Fabrizio, Chiofalo Benito, Buscema Massimo, Valenti Gaetano, Rapisarda Agnese Maria Chiara, Vitale Salvatore Giovanni

机构信息

Unit of Gynecology and Obstetrics, Department of Human Pathology in Adulthood and Childhood "G. Barresi", University of Messina, Messina, Italy.

Unit of Diabetology and Endocrino-Metabolic Diseases, Hospital for Emergency Cannizzaro, Catania, Italy.

出版信息

Int J Endocrinol Metab. 2017 Jan 22;15(1):e43695. doi: 10.5812/ijem.43695. eCollection 2017 Jan.

DOI:10.5812/ijem.43695
PMID:28835764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5554611/
Abstract
摘要

相似文献

1
Evidence-Based and Patient-Oriented Inositol Treatment in Polycystic Ovary Syndrome: Changing the Perspective of the Disease.多囊卵巢综合征中基于证据且以患者为导向的肌醇治疗：改变对该疾病的认知视角
Int J Endocrinol Metab. 2017 Jan 22;15(1):e43695. doi: 10.5812/ijem.43695. eCollection 2017 Jan.
2
[Myo-inositol in the treatment of polycystic ovary syndrome].[肌醇治疗多囊卵巢综合征]
Ceska Gynekol. 2014 Jun;79(3):242-6.
3
Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome.多囊卵巢综合征中肌醇加D-手性肌醇联合治疗的研究进展
Expert Rev Clin Pharmacol. 2014 Sep;7(5):623-31. doi: 10.1586/17512433.2014.925795. Epub 2014 Jun 5.
4
Reflections on inositol(s) for PCOS therapy: steps toward success.多囊卵巢综合征治疗中肌醇的思考：迈向成功的步骤
Gynecol Endocrinol. 2015 Jul;31(7):501-5. doi: 10.3109/09513590.2015.1054802. Epub 2015 Jul 15.
5
Targeting Metabolic Consequences of Insulin Resistance in Polycystic Ovary Syndrome by D-chiro-inositol and Emerging Nutraceuticals: A Focused Review.通过D-手性肌醇和新兴营养保健品靶向多囊卵巢综合征胰岛素抵抗的代谢后果：一项重点综述
J Clin Med. 2020 Apr 2;9(4):987. doi: 10.3390/jcm9040987.
6
The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome.肌醇与D-手性肌醇联合治疗多囊卵巢综合征的理论依据。
J Clin Pharmacol. 2014 Oct;54(10):1079-92. doi: 10.1002/jcph.362. Epub 2014 Jul 18.
7
Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.多囊卵巢综合征（PCOS）与高雄激素血症：一种新的天然关联的作用
Minerva Ginecol. 2015 Oct;67(5):457-63.
8
[The role of inositol deficiency in the etiology of polycystic ovary syndrome disorders].[肌醇缺乏在多囊卵巢综合征疾病病因学中的作用]
Ginekol Pol. 2014 Jan;85(1):54-7. doi: 10.17772/gp/1691.
9
Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach.多囊卵巢综合征中的肌醇：基于病理生理学的方法恢复生育能力。
Trends Endocrinol Metab. 2018 Nov;29(11):768-780. doi: 10.1016/j.tem.2018.09.001. Epub 2018 Sep 27.
10
Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients.联合使用肌醇和D-手性肌醇（40:1）进行治疗，对恢复多囊卵巢综合征患者的卵巢功能和代谢平衡有效。
Gynecol Endocrinol. 2017 Jan;33(1):1-9. doi: 10.1080/09513590.2016.1247797. Epub 2016 Nov 29.

引用本文的文献

1
Molecular Mechanisms in the Etiology of Polycystic Ovary Syndrome (PCOS): A Multifaceted Hypothesis Towards the Disease with Potential Therapeutics.多囊卵巢综合征（PCOS）病因学中的分子机制：针对该疾病及潜在治疗方法的多方面假说
Indian J Clin Biochem. 2024 Jan;39(1):18-36. doi: 10.1007/s12291-023-01130-7. Epub 2023 Mar 18.
2
Treatments in Patients with Polycystic Ovary Syndrome and Effects on Kisspeptin Serum Levels.多囊卵巢综合征患者的治疗及其对 kisspeptin 血清水平的影响。
Maedica (Bucur). 2022 Dec;17(4):799-804. doi: 10.26574/maedica.2022.17.4.799.
3
ANTI-THYROID ANTIBODIES AND THE GONADOTROPHINS PROFILE (LH/FSH) IN EUTHYROID POLYCYSTIC OVARIAN SYNDROME WOMEN.甲状腺功能正常的多囊卵巢综合征女性的抗甲状腺抗体与促性腺激素谱（促黄体生成素/促卵泡生成素）
Acta Endocrinol (Buchar). 2022 Jan-Mar;18(1):79-85. doi: 10.4183/aeb.2022.79.
4
Polycystic Ovary Syndrome Susceptibility Loci Inform Disease Etiological Heterogeneity.多囊卵巢综合征易感基因座揭示疾病病因异质性。
J Clin Med. 2021 Jun 18;10(12):2688. doi: 10.3390/jcm10122688.
5
Chronic Low Grade Inflammation in Pathogenesis of PCOS.多囊卵巢综合征发病机制中的慢性低度炎症。
Int J Mol Sci. 2021 Apr 6;22(7):3789. doi: 10.3390/ijms22073789.
6
Decrease in the Level of Nervonic Acid and Increased Gamma Linolenic Acid in the Plasma of Women with Polycystic Ovary Syndrome after a Three-month Low-glycaemic Index and Caloric Reduction Diet.三个月低血糖指数及热量限制饮食后多囊卵巢综合征女性血浆中神经酸水平降低及γ-亚麻酸增加
Open Life Sci. 2019 Jul 10;14:224-236. doi: 10.1515/biol-2019-0026. eCollection 2019 Jan.
7
Construction of a ceRNA-based lncRNA-mRNA network to identify functional lncRNAs in polycystic ovarian syndrome.构建 ceRNA 相关的 lncRNA-mRNA 网络鉴定多囊卵巢综合征中的功能性 lncRNA
Aging (Albany NY). 2021 Mar 10;13(6):8481-8496. doi: 10.18632/aging.202659.
8
The role of serum β-trophin and endostatin in patients with polycystic ovary syndrome: Are they correlated?多囊卵巢综合征患者血清β-绒毛膜促性腺激素和内皮抑素的作用：它们是否相关？
BMC Womens Health. 2021 Mar 11;21(1):104. doi: 10.1186/s12905-021-01198-4.
9
Androgen Reduces Mitochondrial Respiration in Mouse Brown Adipocytes: A Model for Disordered Energy Balance in Polycystic Ovary Syndrome.雄激素降低小鼠棕色脂肪细胞中的线粒体呼吸：多囊卵巢综合征中能量平衡紊乱的模型。
Int J Mol Sci. 2020 Dec 29;22(1):243. doi: 10.3390/ijms22010243.
10
LncRNA GAS5 is upregulated in polycystic ovary syndrome and regulates cell apoptosis and the expression of IL-6.长链非编码 RNA GAS5 在多囊卵巢综合征中上调，并调节细胞凋亡和 IL-6 的表达。
J Ovarian Res. 2020 Dec 12;13(1):145. doi: 10.1186/s13048-020-00748-y.

本文引用的文献

1
Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS).两种胰岛素增敏剂二甲双胍和肌醇在多囊卵巢综合征（PCOS）女性中的比较。
Gynecol Endocrinol. 2017 Jan;33(1):39-42. doi: 10.1080/09513590.2016.1236078. Epub 2016 Nov 3.
2
How to Achieve High-Quality Oocytes? The Key Role of Myo-Inositol and Melatonin.如何获得高质量的卵母细胞？肌醇和褪黑素的关键作用。
Int J Endocrinol. 2016;2016:4987436. doi: 10.1155/2016/4987436. Epub 2016 Aug 29.
3
Metabolism and Ovarian Function in PCOS Women: A Therapeutic Approach with Inositols.多囊卵巢综合征女性的代谢与卵巢功能：肌醇的治疗方法
Int J Endocrinol. 2016;2016:6306410. doi: 10.1155/2016/6306410. Epub 2016 Aug 4.
4
Current Insights Into Inositol Isoforms, Mediterranean and Ketogenic Diets for Polycystic Ovary Syndrome: From Bench to Bedside.多囊卵巢综合征的肌醇异构体、地中海饮食和生酮饮食的最新见解：从实验台到临床应用
Curr Pharm Des. 2016;22(36):5554-5557. doi: 10.2174/1381612822666160720160634.
5
Inositol's and other nutraceuticals' synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives.肌醇及其他营养保健品的协同作用可对抗多囊卵巢综合征和代谢综合征中的胰岛素抵抗：最新进展与未来展望
Gynecol Endocrinol. 2016 Jun;32(6):431-8. doi: 10.3109/09513590.2016.1144741. Epub 2016 Feb 29.
6
Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with D-Chiro-Inositol.D-手性肌醇治疗后多囊卵巢综合征女性的卵巢功能和代谢因素评估
Arch Gynecol Obstet. 2015 May;291(5):1181-6. doi: 10.1007/s00404-014-3552-6. Epub 2014 Nov 22.
7
Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.多囊卵巢综合征患者肌醇和 D-手性肌醇对卵巢功能和代谢因素影响的比较。
Gynecol Endocrinol. 2014 Mar;30(3):205-8. doi: 10.3109/09513590.2013.860120. Epub 2013 Dec 19.
8
Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients.肥胖型多囊卵巢综合征患者肌醇给药的胰岛素反应差异。
Gynecol Endocrinol. 2012 Dec;28(12):969-73. doi: 10.3109/09513590.2012.685205. Epub 2012 May 21.
9
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.用于患有多囊卵巢综合征、月经过少和生育力低下的女性的胰岛素增敏药物（二甲双胍、罗格列酮、吡格列酮、D-手性肌醇）
Cochrane Database Syst Rev. 2012 May 16(5):CD003053. doi: 10.1002/14651858.CD003053.pub5.
10
Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials.多囊卵巢综合征患者肌醇治疗效果的系统评价：随机对照试验研究
Gynecol Endocrinol. 2012 Jul;28(7):509-15. doi: 10.3109/09513590.2011.650660. Epub 2012 Feb 1.